BioCorRx Inc. (BICX) Financial Statements (2025 and earlier)

Company Profile

Business Address 2390 EAST ORANGEWOOD AVENUE
ANAHEIM, CA 92806
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8808101 156
Cash and cash equivalent8808101 156
Receivables    112
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Prepaid expense303954294572
Other undisclosed current assets 314110211415
Total current assets:118353172152187246
Noncurrent Assets
Operating lease, right-of-use asset1992092187197177
Property, plant and equipment193238455157
Intangible assets, net (including goodwill)888999
Goodwill      
Intangible assets, net (excluding goodwill)888999
Other undisclosed noncurrent assets424242424545
Total noncurrent assets:268290307166202289
TOTAL ASSETS:386644479317389534
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,5755,6825,3304,9774,6494,444
Accounts payable3,0243,0962,8302,7732,4732,390
Accrued liabilities1,3291,3301,3411,2941,2681,246
Other undisclosed accounts payable and accrued liabilities1,2231,2561,159910907808
Deferred revenue      7
Debt1,3431,2881,001803607408
Accrued reclamation costs     43 
Other undisclosed current liabilities1,2901,2549841,3881,1321,088
Total current liabilities:8,2088,2247,3157,1686,4315,947
Noncurrent Liabilities
Liabilities, other than long-term debt15916939841574
Deferred revenue    444
Lease deposit liability   218   
Operating lease, liability159169180 1170
Other undisclosed noncurrent liabilities4,3744,2533,9144,0133,8953,774
Total noncurrent liabilities:4,5344,4224,3114,0173,9103,848
Total liabilities:12,74112,64711,62611,18610,3419,795
Equity
Equity, attributable to parent, including:(12,120)(11,831)(11,001)(10,739)(9,824)(9,132)
Common stock131110999
Common stock, value, subscriptions100100100100100100
Additional paid in capital70,95470,08069,42468,47168,14967,872
Accumulated deficit(83,209)(82,045)(80,557)(79,340)(78,103)(77,134)
Other undisclosed equity, attributable to parent222222222222
Equity, attributable to noncontrolling interest(235)(172)(146)(130)(129)(128)
Total equity:(12,355)(12,003)(11,148)(10,868)(9,953)(9,260)
TOTAL LIABILITIES AND EQUITY:386644479317389534

Income Statement (P&L) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Revenues  441910
Cost of revenue    (2)(13)(4)
Gross profit:  4266
Operating expenses(1,125)(1,660)(1,373)(972)(842)(972)
Other undisclosed operating income    2134
Operating loss:(1,125)(1,660)(1,369)(969)(823)(962)
Nonoperating income (expense)(103)147135(269)(146)95
Other nonoperating income (expense) (1)513813  
Interest and debt expense(122)(77) (34) (37)
Loss from continuing operations before equity method investments, income taxes:(1,349)(1,590)(1,234)(1,272)(969)(904)
Other undisclosed income from continuing operations before income taxes12277 34 37
Net loss:(1,228)(1,513)(1,234)(1,237)(969)(867)
Other undisclosed net income attributable to parent      
Net loss attributable to parent:(1,228)(1,513)(1,234)(1,237)(969)(867)
Other undisclosed net income available to common stockholders, basic 106     
Net loss available to common stockholders, diluted:(1,122)(1,513)(1,234)(1,237)(969)(867)

Comprehensive Income ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Net loss:(1,228)(1,513)(1,234)(1,237)(969)(867)
Comprehensive loss, net of tax, attributable to parent:(1,228)(1,513)(1,234)(1,237)(969)(867)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: